When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Nonsustained ventricular tachycardias

最后审阅: 20 Aug 2025
最后更新: 24 Nov 2023

小结

定义

病史和体格检查

关键诊断因素

  • history of coronary artery disease
  • history of hypertrophic cardiomyopathy
  • history of idiopathic dilated cardiomyopathy
  • presence of other known causes
  • asymptomatic presentation
  • tachycardia
完整详情

其他诊断因素

  • palpitations
  • dizziness
  • lightheadedness
  • presyncope
  • syncope
完整详情

危险因素

  • coronary artery disease
  • left ventricular systolic dysfunction
  • hypertrophic cardiomyopathy
  • idiopathic dilated cardiomyopathy
  • long QT syndrome
  • Brugada syndrome
  • electrolyte imbalance
  • drug toxicity
  • Chagas disease and other cardiomyopathies
  • sleep-disordered breathing
  • catecholaminergic polymorphic VT
  • family history of sudden death
  • mental or physical stress
完整详情

诊断性检查

首要检查

  • ECG
  • electrolyte panel
  • troponin
  • CK-MB
完整详情

需考虑的检查

  • 24-hour ambulatory ECG monitoring
  • echocardiogram
  • cardiac catheterization
  • cardiac MRI with gadolinium
  • electrophysiologic testing
  • stress testing
  • genetic screening
完整详情

治疗流程

持续性治疗

no cardiac comorbidity: asymptomatic and ≤10% NSVT/premature ventricular contraction (PVC) burden

no cardiac comorbidity: symptomatic NSVT or >10% asymptomatic NSVT/premature ventricular contraction (PVC) burden

chronic coronary artery disease (CAD)

post-myocardial infarction (MI)

idiopathic dilated or hypertrophic cardiomyopathy

撰稿人

作者

Fred Kusumoto, MD
Fred Kusumoto

Professor of Medicine

Mayo Medical School

Division of Cardiovascular Diseases

Department of Medicine

Mayo Clinic Florida

Jacksonville

FL

利益声明

FK declares that he has no competing interests.

鸣谢

Professor Kusumoto would like to gratefully acknowledge Dr Ronald R. Butendieck Jr, a previous contributor to this topic.

利益声明

RRB declares that he has no competing interests.

同行评议者

Timothy Markman, MD

Assistant Professor of Medicine

Hospital of the University of Pennsylvania

Philadelphia

PA

利益声明

TM declares that he has no competing interests.

Vias Markides, MB(Hons), BS(Hons), MD, FRCP

Consultant Cardiologist and Chair

Arrhythmias

Royal Brompton & Harefield NHS Trust

Hon. Senior Lecturer

Imperial College

London

UK

Disclosures

VM declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Circulation. 2018 Sep 25;138(13):e272-e391.Full text  Abstract

Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022 Oct 21;43(40):3997-4126.Full text  Abstract

Katritsis DG, Zareba W, Camm AJ. Nonsustained ventricular tachycardia. J Am Coll Cardiol. 2012 Nov 13;60(20):1993-2004.Full text  Abstract

Goldberger JJ, Cain ME, Hohnloser SH, et al. American Heart Association/American College of Cardiology/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. Circulation. 2008 Sep 30;118(14):1497-1518. Abstract

Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary. Circulation. 2008 Jun;117(6):e350-408.Full text  Abstract

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Nonsustained ventricular tachycardias images
  • Differentials

    • SVT with aberrant conduction
    • Electrical artifact
    More Differentials
  • Guidelines

    • 2022 ESC guideline for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
    • 2022 AHA/ACC/HFSA guideline for the management of heart failure
    More Guidelines
  • Patient information

    Heart attack

    Heart attack: what is it?

    More Patient information
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer